Crossmark

Assessment of prostate imaging reporting and data system version 2.1 false-positive category 4 and 5 lesions in clinically significant prostate cancer

Crossref DOI link: https://doi.org/10.1007/s00261-021-03023-w

Published Online: 2021-03-12

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Xiangyu

Liu, Weizong

Lei, Yi

Wu, Guangyao

Lin, Fan https://orcid.org/0000-0003-1595-2736
Funding

Funding for this research was provided by:

the Clinical Research Project of Shenzhen Second Peoples’ Hospital (20193357008)
License Information

Text and Data Mining valid from 2021-03-12

Version of Record valid from 2021-03-12
More Information

Article History

Received: 8 November 2020

Revised: 17 February 2021

Accepted: 25 February 2021

First Online: 12 March 2021

Declarations

:

: The authors declare there are no conflicts of interest regarding the publication of this paper.

: This retrospective study was approved by our institutional review board, and the requirement for written informed consent for all patients was waived.

Document is current

Any future updates will be listed below